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Abstract

Methamphetamine (METH) is a highly addictive drug of abuse that has a severe
impact on neuronal changes in the brain including modulations of plasticity, cognitive
dysfunction, as well as memory impairment. These changes can be seen as modifications
in the expression of biochemical markers associated with synaptic plasticity. One such
marker associated with memory impairment is alpha synuclein (α-syn). Alteration of αsyn expression has been linked to memory impairment in patients with Alzheimer’s
disease (AD) and Parkinson’s disease (PD). Here we assess the effect of chronic METH
treatment in correlation to cognitive functions.
Twenty-nine guinea pigs (male, 150-250 g) were subcutaneously inserted with
ALZET osmotic mini-pumps to deliver either a) saline (24 μl/day), b) METH (10 mg/kg)
per day for 7 days or c) Post METH washout (10mg/kg) . On Day–7, the Novel Object
Recognition test (NOR) was used to assess memory recall. Electrophysiological
techniques were used to assess synaptic plasticity, in the hippocampus CA1 subfield, as it
relates to learning and memory (n=6). Western blots were used to evaluate the expression
of α-syn in the hippocampus.
Saline treated animals (n=7) and the Post METH washout (n=12) showed a
preference for the novel object as compared to the METH treated animals (n=10) that had
a preference for the familiar object.even after 7 days post treatment (n=12). Molecular
assays showed a down regulation of endogenous alpha synuclein protein levels in the
hippocampus between subgroups. Furthermore, long-term potentiation (a cellular
correlate of memory) was maintained in all subgroups.
II

The results from this study warrant the conclusion, that METH affects some of the
same mechanisms underlining memory function and the drug-induced activation lead to
the memory impairments observed in METH addicts and the role of alpha synuclein in
the memory function still remains unclear.

III
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Literature review

1.1 Methamphetamine

The abuse of Methamphetamine (METH) in the United States has increased
markedly in the past 15 years (Cretzmeyer et al., 2003; Rawson et al., 2002; Marshall et
al., 2007). Due to its inexpensive production and low cost, METH is the most synthesized
illegal drug in the USA with an increasing pattern of use in pre-teens and adolescents
(Cretzmeyer et al., 2003) See Figure 1 for molecular structure of METH. Second to
Cannibas, METH is the most popular drug of recreational use in the United States. It is a
synthetic derivative of amphetamine, highly addictive, and chronic use has been linked to
several neurocognitive impairments (Ares-Santos, et al., 2011).
METH can enter the central nervous system (CNS) passively or through the
dopamine transporters (DAT) and acts on the CNS through a non-exocytotic mechanism,
causing the release of monoamine neurotransmitters such as dopamine, norepinephrine
and serotonin (Makisumi et al., 1998). METH has the ability to (i) redistribute
catecholamines from the synaptic vesicles to the cytosol, (ii) reverse the transport of the
neurotransmitters through plasma membrane transporters (Khoshbouei et al., 2003), and
(iii) inhibit the activity of monoamine oxidase (MAO), an enzyme that degrades amine
neurotransmitters such as dopamine, serotonin, and norepinephrine (Barr et al., 2006;
Mantle et al., 1976).
Typically, individuals who chronically abuse METH display signs of acute
toxicity, neurological damage, hypertension, aggression, impaired judgments, seizures,
anxiety, depression and altered behavior and cognitive function (Albertson et al., 1999;
1

Barr et al., 2006; Murray 1998). Neuroimages of METH abusers show many
morphological changes that occur with sustained usage. These changes include persistent
decreases in the levels of dopamine transporters (DAT) in the orbitofrontal cortex,
dorsolateral prefrontal cortex, and the caudate-putamen (Iyo et al., 2004; McCann et al.,
1998; Sekine et al., 2003; Volkow et al., 2001), and a decrease in the density of
serotonin transporters (5-HTT) in the midbrain, caudate-putamen, hypothalamus,
thalamus, and the orbitofrontal, temporal, and cingulate cortices (Sekine et al., 2006;
Aron and Paulus, 2007; Chang et al., 2007). As demonstrated by Thompson et al.,
(2008), METH exposure can result in extensive neuronal damages that can be seen
distinctly in neuro imaging techniques in animals in vivo. For example, magnetic
resonance imaging (MRI) has shown morphological changes in the brain that consist of a
loss of gray matter in the cingulate, limbic and paralimbic cortices, along with significant
shrinkage of the hippocampi and hypertrophy of white matter
METH has relatively high lipid solubility, allowing for more rapid transfer of the
drug across the blood–brain barrier especially in the hippocampus (Martins et al., 2011).
The increase of the drug in the brain can compromise the permeability of the blood brain
barrier in the hippocampus within 24 hours after injection in young adult mice (Martins et
al., 2011). The lipophilic ability of METH is likely attributed to its 10-12 hour plasma
half-life in humans (Schepers et al., 2003; Martins et al., 2011). Furthermore, repeated
exposure of moderate-to-high doses of METH produces blood-brain barrier disturbances
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Methamphetamine Structure

Figure1. The structure of METH. Adapted from
http://www.sigmaaldrich.com/catalog/product/sigma/m8750
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that induce neuronal damages, myelin degeneration, reactive astrocytosis in the parietal
and occipital cortices of the brain (Sharma et al., 2009) and long-term damage to
presynaptic dopaminergic and serotonergic terminals (Wagner et al., 1980; Ricaurte et
al., 1982;Wilson et al., 2003; McCann et al., 1998).
While the cellular and neurochemical repercussions of various METH dosing
regimens have been investigated extensively, less is known concerning the cognitive
function

of humans

and

animals

following

chronic

METH

administrations.

Neuropsychological studies have detected deficits in attention, working memory, and
decision making with active METH use (Gonzalez et al., 2007; Verdejo-Garcia et al.,
2006; Woods et al., 2005). Additionally, withdrawal from METH can produce irritability,
fatigue, impaired social functioning, and intense craving for the drug (Brecht et al., 2004;
Darke et al., 2008; Homer et al., 2008; Sekine et al., 2006; Zweben et al., 2004). Even
after 3 months of abstinence, recovering METH abusers score worse on word recognition
and tests of episodic memory than individuals who do not use METH (Simon et al.,
2004).
Drugs of abuse such as METH can utilize synaptic circuits in the
mesolimbic/mesocortical or the nigrostriatal pathway to induce abnormal drug reward
systems and extreme addictions (Kalivas and Volkow, 2005; Jones & Bonci, 2005,
Hyman et al. 2006) as indicated in Figure 2.

The mesolimbic dopamine pathway

contains neurons that originate in the A10 region of the ventral tegmental area (VTA) of
the midbrain and project to the nucleus accumbens and other structures of the basal
forbrain, including the hippocampus and the caudate-putamen (Bjorklund and Lindvall,
1975).

Wise

and

Bozarth

postulated
4

that

psychostimulants

use

the

mesolimbic/mesocortical pathways to produce euphoric effects in humans (1985). The
nigrostriatal dopamine pathway originates in the substantia nigra pars compacta and
projects into the striatum (Bjorklund and Lindvall, 1975). The nigrostriatal pathway plays
a primary role in movement initiation and control. The functional significance of this
pathway is best illustrated in Parkinsons disease (PD) that results in rigidity, bradykinesia
and some form of memory loss (Bannon et al., 2005).
Taken together, METH use is shown to be associated with neurocognitive
impairments that include poor performance on measures of attention/information
processing speed, learning and memory, and frontal lobe functioning (Kalechstein and
Newton 2003; Quinton and Yamamoto 2006). Memory tasks are the most pronounced
deficits in METH users. These memory deficits have been demonstrated on tests of
verbal (Hoffman et al., 2006), working (Gonzalez et al., 2007), prospective (Rendell et
al., 2009), and episodic memory (Simon et al., 2004). Even after METH use has stopped,
40% of the individuals still experience neurocognitive impairments (Cherner et al.,
2010). Clinically, current and abstinent METH users show impairments in tests of verbal
memory, manipulation of information, and motor performance (Volkow et al., 2001;
Simon et al., 2002; Thompson et al., 2004). These observations further support the
hypothesis that METH has an effect on learning and memory.

5

Synaptic Pathways

Figure 2. Modified diagram of the mesolimbic/nigrostriatal pathways. METH can use
these pathways to induce neuronal damage to the limbic system. Adapted from
www.elsevierimages.com/image/33387.
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1.2 The Hippocampus

As part of the limbic system, the hippocampus is located on the medial surface of
the temporal lobe and has major functions in learning and memory ( Kuno, 1995). The
hippocampus is divided into four sections that include the dentate gyrus, the
hippocampus proper, the subiculum, and the entorhinal cortex. Within the different
sections of the hippocampus, there are several molecular layers that include (1) an
external plexiform layer, which consist of axons of pyramidal cells that project outside
the hippocampus and hippocampal afferent fibers from the entorhinal cortex; (2) stratum
oriens with basal dendrite and basket cells (3), a pyramidal cell layer that contains the
pyramidal cells of the hippocampus, and (4) the stratum radiatum and stratum lacunosum
moleculare (Arbib et al., 1998).
The entorhinal cortex (EC) is the major source of projections into the hippocampus
via the perforant pathway. Two-thirds of the cortical input to the entorhinal cortex
originates in the perirhinal and parahippocampal cortices, which in turn receive
projections from areas in the frontal temporal, and parietal lobes of the brain (Squire and
Zora-Morgan, 1991) As seen in Figure 3, the EC projects to the dentate gyrus (DG) and
the CA3 through the perforant path (pp) (Witter et al., 1988, 2007). In turn, the dentate
gyrus (DG) projects to the CA3 through the mossy fibers (mf). The CA3 projects to the
CA1 through the Schaffer Collateral (SC) and the CA1 projects outside the hippocampus
back to the of the entorhinal cortex in a loop. Also, the CA1 can receive direct
information from the EC and the CA3.
The hippocampus and adjacent structures in the medial temporal lobe memory
7

system function as storage for simple memory (Marr, 1971). The hippocampus is crucial
for rapid acquisition of new information about facts and events, which is available as
conscious recollection (Squire and Zola, 1996).

8

Structure of the Hippocampus

Figure 3. The structure of the hippocampus. The EC projects to the dentate gyrus (DG)
and the CA3 through the Perforant Path. In turn, the DG projects to the CA3 through the
mossy fiber (mf) which projects to the CA1 through the Schaffer Collateral (sc). The
CA1 projects back to the EC. Adapted from en.wikipedia.org
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1.3 Memory

Studies of memory have led to a consensus that memory is not a monolithic, but
rather is supported by multiple brain systems that differ in terms of the types of memory
they mediate. The Multiple Memory Systems Theory states that there are specific circuits
that serve specific classes of learning and memory problems (Squire and Zola-Morgan,
1991). This theory was originally derived largely in part from patterns of impaired and
spared learning abilities following damages to the mammalian hippocampal system
(Cohen and Squire, 1980; Hirsh, 1974; Saunders et al., 1984; Squire, 1992).
According to McGaugh et al. (2000), there are three main memory systems:
working memory, short-term memory, and long-term memory. See Figure 4 for a
schematic of different memory groups. Working memory system occurs immediately
while an event is presently occurring and only last for a few seconds to a few minutes
(McGaugh et al., 1966; Izquerido et al., 1999; Gold et al., 1975; Goldman-Rakic et al.,
1992). The Izquerido et al. (1999), study demonstrate that working memory does not
retain an archive of memories, but rather moment to moment events that may or may not
relate to events already stored in the brain. Working memory serves simultaneous
information, storage, and processing functions (Baddeley, 2000). Working memory
impairments are commonly found in older adults who often have difficulty performing
dual tasks that require both storage and processing (Salthouse, 1996);
Short-term memory, on the other hand, is the ability to acquire new information and
retain it for periods of time ranging from a few seconds or a few minutes and lasts for
several hours (Tulving et al., 1997; Gold et al., 1975). Short term memory requires

10

Memory Systems

Human Memory

Working Memory
(WM)

Short Term Memory
(STM)

Long Term Memory
(LTM)

(< 1 min)

few hours

lifetime

Explicit Memory

Implicit Memory

(Conscious )

(Unconscious)

Declarative Memory
(facts and
experience)

Episodic Memory
(events and
experience)

Procedural Memory
(facts and events)

Semantic Memory
(facts, concepts)

Figure 4. Types of human memories. Adapted from http://www.human-memory.net.
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rehearsal or repetition of the information and sorting or categorization of that information
into systematic chunks. The sorting process is usually called coding or chunking (Gold et
al., 1975). Short-term memory is thought to be translated into long-term memory via
permanent modification of proteins or by the synthesis of new proteins (Costa-Mattioli,
2008; Moncada and Viola, 2007). Long-term memory involves the retention of new
information and lasts from hours to even a lifetime (Levitian and Kaczmarek, 1991).
Long-term memory can further be divided into declarative and non-declarative
memory (Levitian and Kaczmarek, 1991). Declarative memory refers to the capacity to
consciously remember the past and depends on the integrity of the medial temporal lobe
structures (Squire and Clark, 2007). Declarative memory or explicit memory is the
conscious recollection of specific facts and events (Squire and Zola-Morgan 1996).
Explicit memory, a subgroup of declarative memory, is explicitly located in the past and
is accompanied by the feeling of remembering when subjects can retrieve the correct item
(Ennaceur, 2010). This type of long-term memory encourages recognition memory. In
preclinical rodent models, components of episodic memory can be evaluated by an object
recognition task to assess recognition memory (Ennaceur, 2010). Non-declarative
memory or implicit memory is the non-concsious learning capacities that include
memory for skills and procedures (Squire and Zola-Morgan 1996). Non-declarative
memories are procedural skills that are learned through practice such as riding a bike
(Willingham, 1998). It is often slow, learned in segments, and requires immediate and
constant feedback along with repetition ( Willingham, 1998). Consolidation of long-term
memory is slow, passive, and relatively permanent (Wolfman et al., 1994).A neuronal
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mechanism to assess learning and memory is synaptic plasticity. It is a process that is
actively occurring as memory moves from short term to long term memory.
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1.4 Synaptic Plasticity

Learning and memory require persistent changes in neuronal circuits (Nestler et
al., 2004). These changes, according to the Hebbian theory, occur when the connections
between coactive cells change and thereby store a record of the event (Cooper, 2005).
This is due to the increase in synaptic efficiency that arises from the cell’s repeated and
persistent stimulation of the post synaptic cell to induce what is known as synaptic
plasticity. According to Hebb, if the presynaptic and the postsynaptic elements are
coactive and calcium influx is sufficient, then the strength of the synapse increases
(Cooper, 2005). The ability of the brain to adapt and respond to changes in the
environment is referred to as neuroplasticity (Nestler et al., 2004). This plasticity is
important for learning and memory as it is the underlying mechanism for memory
formation (Nestler et al., 2004; Jones & Bonci, 2005). Thus, learning and memory
require neuronal mechanisms that allow rapid, persistent changes to brain circuits to
account for plasticity (Shapiro, 2001). The circuits that are located within the
hippocampus are remarkably plastic, and this plasticity is mediated in part through
changes in synaptic strength..
Synaptic plasticity can be defined by two parameters: (1) the amount of
transmitter released from the presynaptic terminals and (2) the size of the postsynaptic
response produced per unit amount of transmitter (Kandel, 2009). Plasticity occurs when
there are changes in one or both of the parameters. It can be divided into short–term
(minutes to hours) and long-term (days to years) (Kandel and Schwartz, 1982). Longterm synaptic plasticity is a form of plasticity that is relevant in the efficiency of learning
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and memory in the brain because it also requires changes in synaptic structures and gene
expression (Malenka and Bear, 2004; Kandel, 2009). The most well-known and studied
mechanism of neural plasticity is long-term potentiation (LTP) or long-term depression
(LTD) as these long-lasting synaptic changes are widely believed to be the cause of many
forms of long lasting memory changes ( Bliss and Lomo, 1973; Kandel, 2009)
LTP is defined as an activity-dependent enhancement of synaptic strength and is
the general cellular model of learning-induced plasticity in the hippocampus (Bliss et al.,
1973; Clarke et al., 2010). The term LTP was coined by Bliss and Lomo in 1973, in an
experiment when a brief tetanic stimulation (10-100 hertz for 3-20 sec) was applied to the
perforant path presynaptic fibers in the dentate gyrus of a rabbit. The postsynaptic
response was recorded from the granular cells of the hippocampal formation and lasted
for more than 3 days (Bliss and Lomo 1973). The results suggested that two independent
mechanisms were responsible for LTP: an increase in the efficiency of synaptic
transmission at the perforant path synapses and an increase in the excitability of the
granule cell population (Bliss and Lomo, 1973).
Classic LTP has been characterized by two phases, (1) early-LTP that is initiated
in the absence of protein synthesis (1-2 hrs) and (2) a late-LTP that requires the synthesis
of new proteins and lasts longer than 3 hours (Huang and Kandel ., 1998). Early-LTP is
typically initiated with a single train of high-frequency stimuli (100 Hz, 1 sec) and starts
immediately after post-tetanic stimulation (Huang and Kandel., 1998; Kandel, 2009).
Once early-LTP is initiated, it is maintained by the activation of NMDA receptors which
leads to the influx of calcium and leads to the activation of secondary messengers
(Malenka et al., 1988; O’Dell and Kandel et al., 1991). It has been suggested that early15

LTP may involve temporary modifications of existing protein (Malenka et al., 1988;
Huang and Kandel 1998,). Late-LTP is typically initiated with three trains of highfrequency stimuli (100 Hz, 1 sec, at 60 sec intervals) and typically starts three hours after
post-tetanic stimulation (O’Dell and Kandel et al., 1991; Pittenger et al., 2006). Late-LTP
also requires the activation of the N-Methyl-D-aspartate (NMDA) receptors, voltage
dependent calcium channels, and may require protein synthesis (Raymond, 2007; Nguyen
et al.; 2003).
LTP can also be measured by changes in plasticity as represented by ongoing
molecular events in the cell. The major excitatory transmitter substance in plasticity is
NMDA (Kuno, 1995). According to Shapiro NMDA receptors are crucial for inducing
these plastic changes, and blocking these receptors reduces plasticity and impairs learning
in tasks that require the hippocampus (2001). Modifications, such as the introduction of a
drug or a NMDA antagonist can disrupt signaling mechanisms downstream of the
NMDA receptor, leading to the prevention of LTP induction and to the impairment of
hippocampus-dependent learning (Kuno, 1995).
In the hippocampus, NMDA receptors are commonly implicated in activating
nuclear gene transcription (Worley et al., 1993; Ghosh and Greenberg, 1995; Finkbeiner
and Greenberg, 1998). As indicated in Figure 5, once NMDA receptors are activated by
neurotransmitters, a signal is generated to secondary messengers to activate also. The
increase in second-messenger levels that occurs activates different protein kinases, such
as protein kinase A (Shaywitz and Greenberg, 1999) and calcium- and calmodulindependent kinase IV (Ginty 1997; Shaywitz and Greenberg, 1999; Wu et al., 2001). The

16

Summary of Transcriptional Regulation by Neurotransmitters

Figure 5. Summary of the overall biochemical cascade by which ligands such as METH
can alter gene transcription in the nervous system.
Adapted from:
www.chemistry.emory.edu
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nuclear targets for the activated kinases include many things, such as regulatory
transcription factors (RTFs) like the cAMP response element binding protein
(CREB).CREB binds to a cAMP response element (CRE) in many gene promoters
including growth factors, enzymes, other transcription factors, and structural proteins
(Ginty 1997; Lonze and Ginty, 2002). CREB can also be modified in various ways that
can lead to changes in its activity or stability (Johannessen et al., 2004). When CREB
binds to CRE it becomes “active” due to the phosphorylation that occurs at Ser-133
(Ginty, 1997). Studies have shown that late-phase LTP at the cortical synapses lead to
the increase of Ser-133 phosphorylation of CREB and this increases the CREB activity in
the hippocampus (Johannessen et al., 2004; Shaywitz and Greenberg, 1999)). This
prolonged Ser-133 phosporylation of CREB is observed when it is activated by upstream
modulators of extracellular signal-regulated kinases (ERK) and may play a role in the
maintenance of LTP and normal memory (Wu et al., 2001).
Additionally, CREB activity is increased in reward-related areas of the brain
following chronic or acute treatment with psychostimulates such as amphetamine and
cocaine (Konradi et al., 1994; Hyman et al., 1996;). The increases in CREB activity
following chronic drug use suggest involvement in the reward-related drug addictions
and the modification of gene expression (Nestler, 2004).
We have reviewed that chronic drug use has severe impacts on memory
formation, reactivation, and reconsolidation suggesting that neuronal changes are
occurring within the brain (Huang and Kandel, 1998). These changes in long lasting
neuronal plasticity have been the accepted model to study memory formation.

18

1.5 Alpha Synuclein

The synucleins are small soluble presynaptic proteins expressed primarily in the
neural tissue (George, 2002). The synuclein family consists of three distinct proteins that
have been described only in vertebrates (Spillantini et al., 1995). The alpha and beta
synuclein proteins are found in abundance primarily in the brain tissue while the gamma
protein is found primarily in the peripheral nervous system and retina (George, 2002).
The first synuclein was identified from a purified cholinergic vesicle from the electric
organ of the Pacific electric ray Torpedo californica where it was found in both the nerve
terminals and the nuclear envelope (Maroteaux et al., 1988).
Alpha–synuclein (α-syn) is a small protein of 140 amino acids, 17 kda, that is
localized in the cytosol of the presynaptic terminal of neuronal tissues. α -syn is
predominately expressed in the hippocampus, neocortex, thalamus, and the substania
nigra (Yoshimoto et al., 1995; Murphy et al. 2000; Barr et al., 2006; Schultz-Schaeffer,
2010). It belongs to a family of loosely folded proteins (Weinreb et al., 1996; Uversky et
al., 2001). Although cellular functions have not been determined for any of the synuclein
proteins, but mutations in the α-syn gene have been implicated in many
neurodegenerative diseases such as Alzheimer’s and Parkinson disease through abnormal
accumulation, gene triplication, or misfolding (Polymeropoulous et al., 1997).
Researchers have suggested α-syn may play a role in modulating numerous
cellular functions. These roles include (1) modulating vesicular synaptic release (Murphy
et al., 2000), (2) cell signaling, (Kurz et al., 2010), (3) neuronal plasticity (Clayton and
George, 1998), (4) synaptic function maintenance ( Petersen et al., 1999), (5) regulation
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of distinct pools of synaptic vesicles in mature neurons (Murphy et al., 2000), (6)
inhabitation of phospholipase D activity which is linked to pathways of cell growth,
neurotransmitter release and differentiation (Jenco et al., 1998;), (7) defensive role in
response to neuronal cell injury (Kholodilov et al., 1999), functions in oxidative stress
(Lee et al., 2006;), and (8) synaptic release by promoting SNARE complex assembly
(Perez et al., 2002)
One study has suggested that under normal physiological conditions, α-syn exists
in an α-helix rich tetramer that is not prone to aggregation (Bartels et al., 2011). However
under disease conditions, the protein may misfold into β-sheet-rich conformations and
aggregate into fibrils which are the main components of Lewy bodies and Lewy neurites.
A classical Lewy body is an eosinophilic cytoplasmic inclusion that consists of a dense
core surrounded by a halo of 10 nm-wide radiating fibrils, the primary structural
component of which is α-syn (Bartels et al., 2011; Spillantini et al., 1998;).

Under

abnormal physiological conditions, disruption of the local alpha helical structure can
occur and the β-pleated sheets can be extended to render mutant α-syn that is more prone
to self aggregation and abnormal deposition in the brain (Kruger et al., 1998;
Polymeropoulous et al., 1997).
Alpha-syn is often associated with neurodegenerative diseases associated with
cognitive declines such as Alzheimer disease (AD) and Parkinson’s disease (PD) (Norris
et al., 2004). Other studies have shown that an over expression of α-syn or a missense
mutation on the gene can lead to rare forms of PD (Polymeropoulos et al., 1997;
Spillantini et al., 1998). In the familial form of PD, there is a missense in the α-syn gene,
Ala53Thr (Polymeropoulous et al., 1997) or Ala30Pro (Kruger et al., 1998). PD is
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clinically classified as a movement disorder characterized by tremor, rigidity,
bradykinesia, and a progressive loss of dopaminergic neurons from the substania nigra
containing Lewy bodies and Lewy neuritis surrounded by a halo constructed by α-syn
(Forno et al., 1996). Filamentous α-syn has been shown to be the major component of
these deposits that have been seen in the identification of mutations in the early onset of
familial PD (Spillantini et al., 1998; Polymeropoulous et al., 1997). A study by Kirik et
al., suggested that Parkinson-like degeneration is induced by a targeted over expression
of α-syn using viral vectors in the nigrostriatal system in mice (2003).
Although the ability of α-syn to form fibrils has been demonstrated in numerous
in vitro studies, the molecular mechanism of this process remains unclear. One possible
mechanism in the formation of α-syn fibril involves a c-terminally truncated α-syn
(Crowther et al., 1998). These truncated forms of α-syn (1-131, 1-120, 1-81) are able to
assemble into filaments similar to those found in neurodegenerative diseases (Crowther et
al., 1998; Uversky et al., 2001). Another mechanism points to the absence of significant
secondary structure and the lack of hydrophobic core of α-syn, as viewed by UV
spectroscopy (Kim, 1997; Weinreb et al., 1996), may lead to α-syn transformation from
the normal soluble form of the monomeric protein into an insoluble conformation
(Uversky et al., 1998). This is a critical step before fibril formation which is initiated by
nucleation, followed by oligomerization, and leads to profibrils and finally fibrillization
(Uversky et al., 1998). Recent studies have revealed that the accumulation of α-syn can
result in immediate formation of different sizes and shapes of oligomers (Conway et al.,
2000; Tsigenly et al., 2008;). These oligomers interact with lipids, disrupt membranes,
and cause cell death in vitro in non-mammalian models (Conway et al., 2000). These α-
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syn oligomers increase intracellular calcium levels, decrease cAMP response elementbinding protein (CREB) transcriptional activity, and have a detrimental impact on
neuronal welfare and memory functions in cultures neuroblastoma cells of the
hippocampus (Martin et al., 2011). According to Martin et al., (2011) CREB inhibition
and calcineurin induction were observed when α-syn oligomers were applied to brain
slices. This interfered with hippocampal long-term potentiation and impaired memory
through a calcineurin-dependent mechanism (2011).

In fact, oligomer toxicity is

exemplified in some forms of PD such as the juvenile form in the absence of Lewy body
formation (Olanow et al., 2004).
A recent study has suggested that fragments of α-syn can associate with amyloid
plaques and promote the aggregation of α-syn in the limbic regions of Alzheimer’s
patients in vivo (Crews et al., 2009). Furthermore, it is speculated that α-syn olgimer
accumulation specifically damages limbic structures that are associated with the
neurodegenerative disorders such as Alzheimer’s disease and Parkinson’s disease and
may cause memory deficits (Hashimoto et al. 2003; Braak and Braak 1999;). However a
study by Lim et al., 2011, suggests the suppression of α-syn can cause the reversal of
synaptic and memory defects in mouse models with dementia and lewy bodies (Lim et
al., 2011). This may suggest that α-syn is likely to play a role in memory formation and
plasticity (George et al. 2002; Lim et al., 2011) For this study, a novel object recognition
(NOR) behavioral task, electrophysiology and methamphetamine as a pharmacological
agent will be used to investigate the effects of α-syn on memory consolidation.
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Alpha synuclein Fibrils

Figure 6: Electron micrograph of in vitro assembled α-syn fibrils. Taken from
http://www2.mrc-lmb.cam.ac.uk/archive/papers/CP72-12.pdf
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Specific Aims

The aim of this study was to determine if chronic METH administration causes molecular
and behavioral modification associated with α-syn expression. Since α-syn accumulation
has been implicated in memory impairment, we addressed the following:

(1) To access the effect of chronic METH on memory consolidation and synaptic
plasticity by using novel object recognition test (NOR) and Electrophysiology as
assessment tools, and

(2) Evaluate if METH alters α-syn expression in the hippocampus

It is hypothesized that chronic METH interferes with memory formation partly as a
consequence of drug-induced alterations in α-syn expression.
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2. Materials and Methods
2.1 Animals
Twenty-nine male Hartley (HA) guinea pigs (2 weeks old; 200-250 g) were
obtained from Charles Rivers Laboratory (Wilmington, MA). The animals were housed
in groups of two per cage (18.5 x 18.5) at the Animal Care Facility (ACF) Center at
Meharry Medical College (Nashville, TN). They were kept in a 12:12 hr light/dark cycle
for at least 3 days prior to any drug treatment or experimental procedures. The ACF
maintained the animals in temperature controlled rooms at 65-70 °F. The animals were
housed for a maximum of 21 days total. The animals had access to food and water ad
libitum. A maintenance record of each guinea pig was kept indicating date of arrival,
weight, age, date used, and treatment regimen. Animals were processed in accordance
with guidelines and regulations of the Institutional Animal and Care and Use Committee
(IACUC) for the use of vertebrate animals.

2.2 Pharmacology
METH, obtained from Sigma (CAS # 51-57-0; St. Louis, MO), was administered to
guinea pigs to determine its effect on recognition memory, synaptic plasticity and
expression of α –synin the hippocampus. Each guinea pig was weighed prior to surgery to
calculate the appropriate amount of METH dosage to ensure that 10 mg/kg would be
received throughout a 24 hour period through the azlet mini pump (Durect Corporation;
Cupertino, CA). METH was dissolved in Phosphate Buffer Saline (PBS).
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2.3 Surgery
Guinea pigs (n=29) were anesthetized with (4%) isofluorane as general
anesthesia. Alzet mini-pumps (Durect Corporation; Cupertino, CA) were implanted
subcutaneously on the back of the guinea pigs and were set to deliver a continuous
infusion of METH ( 10 mg/kg; Sigma; St. Louis, MO) or saline (0.9% NaCl solution for
7 or 14 days. The incisions made in the skin were sutured closed with surgical staples and
the guinea pigs were allowed to recover from the local anesthesia.

2.4 Treatments
The basic treatment designs in the studies are in Figures 7 – 9. All guinea pigs were
used in Novel Object Recognition (NOR) (n=29) task after the appropriate treatment was
given. Guinea pigs were randomly assigned to electrophysiology (n=6), molecular
analysis (n=14), and the remaining animals were used for other studies. For the molecular
analysis, guinea pigs were assigned to one of three experimental groups that were
identified as (a) 7 day METH treatment, (i.e. 10 mg/kg/day; n=6), (b) Post Washout
group, (i.e. 10 mg/kg; n=6), (c) Saline, (i.e. 0.9% NACL; n=2). The Post Washout group
had 7 days of continuous METH infusion followed by 7 days of no drug (i.e. METH)
treatment. The treatment groups (n=12) were subjected to treatment of high dose METH
(10 mg/kg) per day as illustrated in Figure 7 while the saline group was subjected to
treatment of saline (i.e 0.9% NaCl solution; n=2). The appropriate treatments were
administered using an Alzet osmotic mini-perfusion pump for a period of 7 or 14 days at
a rate of 1.0 µl per hour or 24 µl of saline in each 24-hour period
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Treatment Design

Figure 7. Treatment plan for all guinea pigs (n=29). All of the guinea pigs did go through
NOR (n=29). For electrophysiology (n=6) and molecular analysis (n=14) animals were
randomly assigned. Out of the METH set two animals went through electrophysiology
and six were used for molecular studies. Out of the saline set two animals went through
the electrophysiology and the remaining two were further assessed for molecular studies.
Out of the Post METH group two animals went through electrophysiology and six were
used for molecular studies.
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7 day METH Experimental Design

Figure 8: Animals arrived on day 0 and were acclimatized for a period of 3-4 days. Alzet
mini-pump implants were inserted on day 3. Drug treatments were performed on the
same day for all guinea pigs (n=29). Guinea pig handling occurred on day 7-9 for the 7
day METH (n=10) and saline (n=2). NOR testing occurred on day 10. Euthanization of
animals and tissue harvest occurred on days 11 and 12 for future molecular testing.

Post Washout Experimental design

Figure 9. Post washout period (n=12) occurred between days 9-15. GP handling for Post
Washout (n=12) and Saline (n=3) occurred on days 16-18. NOR behavioral assessment
occurred on day 19. Euthanization of animals and tissue harvest occurred on days 19-20
for further molecular studies.
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2.5 Behavioral Assessment
The Novel Object Recognition test (NOR) is a behavioral task technique that is used to
assess memory recall. Memory recall is a way to obtain information from your memory
without having a cue or a trigger to activate past information or episode while recognition
memory requires a trigger or a cue for memory activation of past information or episode
(Haist et al., 1992 ). Recognition memory refers to the ability to judge a previously
encountered item as familiar. Recognition memory is widely viewed as consisting of two
components: recollection and familiarity (Malmberg, 2008; Atkinson and Juola, 1974).
Recollection involves remembering specific contextual details about a prior learned
episode and familiarity involves simply knowing that an item was presented, without
having any available additional information about the learned episode. Tasks that assess
recognition memory (and object recognition memory) in particular, have become
increasingly useful tools for basic and preclinical research investigating the neural basis
of memory (Winters et al. 2008). NOR consist of three phases: the familiarization phase,
the delay phase, and the testing phase (Clark and Martin, 2005).
2.5.1 Guinea Pig handling/Habituation
All guinea pigs (n=29) were handled for 5 minutes each day for 3 consecutive
days to allow acclimatization to the testing environment and to the researcher. After the
handling phase, the guinea pigs were allowed to explore and become familiar with the
empty Nodulus Phenotyper, Home Cages (18.5 x 18.5), designated as the testing arena,
(Leesburg, VA) for 5- additional minutes. In all experiments, the Phenotyper home cages
were cleaned prior to each phase of the experiment. See Figure 10 for diagram of
Phenotyper.
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2.5.2 Re-habituation
At the beginning of the trial period, each guinea pig was placed in a Nodulus
Phenotyper Home Cage and was allowed to explored the cage for 5 minutes. Guinea pigs
were removed and placed in a transport box for 15 minutes, and two identical objects
were placed in the Nodulus Phenotyper Home Cage. See Figures 11 and 12 for
experimental diagram for the NOR test.

2.5.3 Familiarization
The guinea pig was returned to the Nodulus Phenotyper Home Cage and allowed
to explore the two identical objects for 5 minutes.

2.5.4 Delay
The guinea pig was removed from the Phenotyper Home Cage and taken back to
his individual home cage for a 3 hour interval. During the delay phase a novel object
along with one familiar object was placed in the Phenotyper Home Cage.

2.5.5 Testing
After completion of the 3 hour delay interval, the guinea pig was returned to the
Phenotyper Home Cage and was given the opportunity to explore the two objects, one
which was novel for 5 minutes. See Figures 11 and 12 for NOR experimental schematic.
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Nodulus Phenotyper

Figure 10. Phentotyper where NOR assessment took place. The cage is 18.5” x 18.5” and
equipped with a video tracker (A) which monitors the animal’s behavior and movement
throughout the cage. In this diagram B indicates the water bottle for the animal, and C
indicates the door in which the animals enter the phenotyper. Adapted from
http://www.noldus.com/.
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2.5.6 Processing

After the NOR tests were completed most of the guinea pigs were euthanized with an
overdose of pentobarbital (150 mg/kg body weight i.p.). Both hippocampi were harvested
and preserved in RNAse Later (Ambion; Camarillo, CA) for subsequent molecular
studies. Of the remaining guinea pigs, six were randomly selected to be processed electro
physiologically to access synaptic changes in the hippocampus (see Electrophysiology
section below).
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Basic Novel Object Recognition Test

Figure 11. The basic experimental layout for the NOR behavioral assessment test for the
guinea pig (n=29) includes the familiarization phase, the exploration of two identical
objects for 5 minutes, and the test phase which includes the exploration of two objects,
one of which is novel, for 5 minutes after a 3 hour delay.

Figure 12. Basic experimental layout for the NOR behavioral assessment test for the
guinea pigs (n=29) includes habituation, familiarization and, the Nor test (administered
after a 3 hour interval).
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2.5.7 Analysis:
EthoVision XT (Nodulus,Virgina) software was used for the automatic tracking
and analysis of animal movement, activity, and behavior in the Nodulus Phenotyper. To
assess recognition memory, the amount of time spent exploring the novel object verses
the familial object was evaluated.

A discrimination index (DI) was calculated by

subtracting the total time spent with the new object from the familiar object and dividing
this value by the sum of the time spent exploring both objects. DI = (Time exploring
NOV – Time exploring FAM)/ (Total time exploring NOV + FAM). A Positive DI values
indicated a preference for the novel object which is suggestive of memory consolidation.
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2.6 Electrophysiology
Guinea pigs were anesthetized with urethane (1500 mg/kg i.p.) dissolved in
phosphate buffered saline (PBS) and were given Buprenorphine analgesic (.03 mg/kg;
i.m.). To ensure that the animal was anesthetized, noxious stimulus such as pinching of
the ear and hind limbs was done. If the animal twitched, withdrew a knee, or increased
breathing was noticed, the animal was given a booster dosage of anesthesia, which was
approximately 10-15% of the start dose. Each animal was firmly secured in a stereotaxic
apparatus, with ear bars and mouth piece to stabilize the head. The top of the animal’s
head was shaved and disinfected with alcohol wipes, after which, a subcutaneous
injection of 2% lidocaine was injected under the skull as local anesthetic (0.2-0.3 mL). A
circular patch of skin 2-3 cm was made to expose the skull. As needed hydrogen peroxide
(30%) was used to clean the exposed skull to prevent further bleeding. The bregma was
identified as the zero reference point for determining hippocampus coordinates for
electrode placement. Small access holes (~2 mm diameter) were made in the skull to
allow for the lowering of bipolar tungsten stimulating electrodes (SNEX-15, Rhodes) in
the left CA3 region (-4.5 mm posterior, 5 mm lateral and -5.0 mm vertical relative to
bregma) and in the left CA1 region (-5.0 mm posterior, 2.5 mm lateral and -3.5mm
vertical rise relative to bregma). Stimulation was applied to activate the CA3 neuron
region and elicit population spike responses within the CA1 region. Once all electrodes
were in place, recordings proceeded while monitoring vital signs. See Figure 13 for
schematic of recording.

Appropriate measures were undertaken to make sure each

animal remained fully anesthetized. To maximize animal comfort, during the recording
guinea pigs were blanketed with warming pads in order to maintain regular body
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temperature. Animal experiments were performed with strict adherence to protocols
approved by the Institutional Animal Care and Use Committee. Stimuli were adjusted
(100 -150 µA for 0.01 msec at 1 Hz) to evoke CA1 field potentials with amplitudes
between 0.5 -1.0 mV. This response was monitored for 30 minutes. After the 30 minutes
of stable recording, a high frequency tetanic stimulation was applied to elicit LTP (100
Hz, 1sec, 3 trains at 60 sec intervals). The evoked population spikes were monitored for
at least another 180 minutes at the original stimulation (100 -150 µA for 0.01 msec at 1
Hz. The recorded population spike and spontaneous field potentials were amplified at a
gain of 1000 X and filtered between 1Hz and 5 kHz using an AC amplifier. All
population spike recordings that were acquired during the sessions were stored in the
computer using pCLAMP10 software. At the end of the recordings, the guinea pigs were
euthanized with an overdose of pentobarbital (150 ml/kg body weight i.p.). The whole
brain was immediately removed and stored in isopentane for subsequent molecular
studies (i.e. in situ or Western blot).
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Electrophsiology Recording

Figure 13. An in vivo animal model. Stimulation in the left CA3 area evokes population
spikes in the left CA1 sub-fields. We recorded spontaneous and evoked population spike
in the left CA1 area only.
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2.7 Analysis
The basic parameters were extracted from the recorded field potentials and this
included amplitude, onset latency, and duration. However only the change in the
amplitude as a function of time was analyzed. The field potential typically has a positivegoing wave (PW1) that is interrupted by a negative-going population spike (PS),
followed by another positive-going wave (PW2). PW1 reflects synaptic depolarization
whereas PW2 corresponds to the input to CA1 cells (Anderson et al., 1964). The PS is
due to a summation of discharging of CA1 neurons (Anderson et al., 1971). The basic
criterion for the detection of late-LTP was enhancement in post-conditioning synaptic
responses, lasting beyond 2 hrs (one-way ANOVA with Scheffe’s test as the a posteriori
test (α < 0.05)).

2.8 Molecular Studies:

2.8.1 Protein Isolation
The total protein was isolated from frozen hippocampal tissue samples previously
stored in RNA later. The tissue sample is first washed in PBS and the weight of the tissue
sample was recorded before homogenization. About 600 µL (or 6-8 volumes per tissue
mass) of ice-cold Cell Disruption Buffer (Invitrogen; Camarillo, CA) was added into a
tube with the tissue sample and homogenized using the Pro 200 motor rotor-stator
(Invitrogen; Camarillo, CA). The mixture was centrifuged at 16,000 x g for 20 minutes at
4° C. The pellet was then discarded and the supernatant, was aliquoted and stored until
used.
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2.8.2 Protein Concentration Determination via Bicinchoninic Acid Assay
Protein concentration was measured using the Pierce Bicinchoninic Acid (BCA)
Protein Assay as described by the manufacturer (Thermo Scientific, Rockland, IL).
Bovine serum albumin (BSA) was used as a standard. This technique is based on the
reduction of CU++ to CU+ by protein in an alkaline medium as follows:
1. Protein (peptide bonds) + Cu++  tetradentate-Cu+ complex
2. Cu++ +2 BCA   BCA-Cu+ complex (purple color)
This purple color reaction product exhibits a strong absorbance at 562 nm that increases
linearly with increasing protein concentration over a broad range of 20-2000 µg/ml. To
determine the sample concentration, a plot was made of the values of BSA verses their
known concentrations (ranging from 0 to 2000 µg/ml). A linear regression line was fitted
from which the slope coefficient was calculated. At the same time several dilutions of
each sample were also assayed and the calculation was obtained by taking the mean
scored and dividing by the slope coefficient obtained from the BSA standard plot to
obtain protein concentration for each sample.

2.8.3 Protein Analysis
Protein bands were separated according to their weights using the standard
procedures of the NuPage MES kit on a precast 4-12% NuPAGE Novex Bis-Tris Gel
(Invitrogen; Camarillo, CA ). Individual samples were made according to the constituents
shown in Table 1. Samples were heated for 10 minutes at 70°.

Proteins were

electrophoresed and in duplicates using the MES Running Buffer as shown in Table 3.
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SDS-PAGE separation occurred for 35 min at 200V. After the completion of
electrophoresis, the gels were transferred on a polyvinylidene fluoride (PVDF) membrane
at 25V for 60 minutes using the Novex XCell blotting apparatus. The blotting sandwich
was prepared and carefully inserted into the 1X transfer module in the Novex XCell unit
with the transfer buffer. See Table 2 and Figure 14.
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NUPAGE Reduced sample preparations

20 μL
2.5 μL
1 μL
6.5 μL
10 μL

Sample
NuPAGE® LDS Sample Buffer (4X)
NuPAGE® Antioxidant Reducing Agent
Deionized Water to
Total Volume

Table.1. Preparation of Reduced samples for denaturing gel electrophoresis using the
NuPAGE Novex Bis-Tris

NUPAGE MES Running buffer

NuPAGE SDS Running buffer (20X MOPS)
Deionized Water
Total Volume

50 mL
950 mL
1,000 mL

Table 3. Preparation of the Running buffer.

NUPAGE MES Reduced Transfer buffer

NuPAGE Transfer Buffer (20X)
NuPAGE® Antioxidant
METHanol
Deionized Water
Total Volume

50 mL
1 mL
100 mL
849 mL
1,000 mL

Table.2. This transfer buffer was used during the transfer phase to ensure maximum
protein transfer from the gel to the PVDF membrane.
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Transfer Apparatus

Figure 14. Depiction of Novex XCell II blotting apparatus set-up. Transfer sandwich was
built from the base up with two blotting pad, filter paper, gel, PVDF transfer membrane,
filter paper, and lastly blotting pad.
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2.8.4 Western Blot Procedure for Alpha Synuclein
After the removal of the PVDF membrane from the transfer buffer, the membrane was
washed briefly with 1X Tris-Buffered Saline and 10% Tween-20 (TBST). The membrane
was rinsed off and incubated in blocking solution (10 ml of 5% milk in TBST) for 1 hour.
15 µl of polyclonal rabbit α synuclein (; Santa Cruz Biotechnology; Santa Cruz, CA,
dilution 1:200) was added to 10 ml of 5% milk and the membrane was incubated overnight
at room temperature. The following morning, the membrane was washed in three washes of
TBST, 5 minutes each, and incubated with anti-rabbit secondary antibody conjugated to
horseradish peroxidase (Bio-Rad, Hercules, CA) in 5% milk in TBST blocking solution for
1hr at room temperature. After the incubation, the membrane was washed in three washes
of TBST, 5 minutes each. For signal development, the Detection Reagent Working
Solution, Reagent 1 and Reagent 2, were used from the Fast ECL kit

(Thermoscientific,

Rockland, IL). After mixing the Detection Reagent Working Solution in a 1:1 dilution, the
solution was poured onto the membrane (approximately 3 ml of mixture per membrane).
The detection reagent working solution interacted with the membrane for about 1 minute.
The membrane was removed from the detection solution and was wrapped in a clear plastic
wrap. The membrane was placed in a cassette tape and developed on film in a dark room
for the appropriate time of 1 minute. Figure 15 shows a schematic of the Western blot
procedure.
After film exposure, the membrane was washed with TBST for 5 minutes to rinse
off the detection agent. Membrane was re probed with 0.5 µl GAPDH

mouse

monoclonal (Life Technologies; Camarillo, CA) in 10 ml of 5% milk/TBST incubated
overnight at room temperature. Then, the membrane was removed from the antibody
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solution and washed three times in TBST for 5 minutes. The membrane was then
incubated with 0.5 µl

anti-mouse monoclonal (Santa Cruz Biotechnology; Santa Cruz,

CA) for loading control purposes in 10 ml of 5% milk/TBST and immunoreactivity was
visualized with the Fast ECL kit (Thermoscientific, Rockland, IL) as described above.
After development and exposure, the film was scanned and analyzed using the AlphaEase
FC 4.0 (Alpha Innotech; San Leandro, CA).
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Western Blot Procedure for Alpha Synuclein

1) Protein Isolation/
Determine protein
concentration
(BCA Kit)

2) Electrophoresis
Settings: 35min, 200V,
125 mA

3) Transfer on PVDF
membranes
Settings: 30V, 60 minutes,
125 mA

4) Block for an 1 hour 10
ml of 5%milk/TBST

8) Strip/Add .5µl GAPDH
mouse mooclonal primary
anitbody to 10ml of 5%
milk/TBST)

7) Wash/Expose to
Detection Reagents from
Fast ECL kit/ expose to film
and analyze data

9) Wash/Add .5µl on antimouse monoclonal as
secondary in 10ml of 5%
milk/TBST)

9) Wash/Expose to
Detection Reagents from
Fast ECL kit/ expose film
and analyze with loading
control

6) Washes/ anti-rabbit
seconary antibody
conjugted HRP
(5µL) per 10ml of 5% milk)
1 hr

5) Added polyclonal rabbit
primary antibody (15µl per
10ml of 5% milk/TBST)
overnight

Figure 15. Flow Chart depicting molecular procedures used to assess α-syn expression in
the guinea pig hippocampus after drug treatment with METH.
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3. Results

3.1 NOR Behavioral Assessment

Twenty-nine animals were used to access recognition memory in the hippocampus. The
technique used in this evaluation was the Novel Object Recognition (NOR) task that
evaluated recognition memory, the amount of time spent exploring the novel object
verses the familial object. NOR was evaluated by using the Discrimination Index (DI). A
discrimination index (DI) was calculated by subtracting the total time spent with the new
object from the familiar object and dividing this value by the sum of the time spent
exploring both objects. Figure 16 shows the discrimination index (DI) for the novel
object for each subgroup (i.e., Saline, Post Washout, and METH). Exploration of the
objects by the guinea pigs (n=29) included sniffing, touching or time when the head
region was within a defined perimeter around the object (FAM or NOV etc). On testing
day the interval between familiarization and NOR testing was 3 hours. Both the Saline
group and the Post Washout group exhibited a preference for the novel object on the
NOR task as indicated by a positive DI. The important finding was that the Post Washout
group exhibited preference for the novel object, but the METH group only showed a
preference for the familiar object. The overall pattern of exploration through the NOR
test was different in the three groups, but the Saline group (0.63 +/- 0.05) exhibited a
much stronger preference for the novel object than did the Post Washout (0.15 +/- 0.06).
Importantly, the METH group did have a preference for the familiar object (-0.21 +/0.07) as shown in Figure 16. In fact, the METH group had a negative discrimination
index which suggests this group did not have a preference for the novel object. This
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affect by the METH group was statistically significant when compared to the saline
groups (p > 0.05) using the 1-way ANOVA with Tukeys post-hoc tests.
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Figure 16. A positive DI indicates a preference for the novel object and our results show
guinea pigs in the saline group and Post Washout obtained positive scores on the NOR,
i.e. showed preference for the novel object. While the METH group obtained a negative
score on the NOR, i.e. did not show a preference for the novel object.
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3.2 Electrophysiology

3.2.1 Evoked Potentials
Guinea Pigs (n=6) were used to evaluate the synaptic plasticity across the
CA3/CA1 region of the hippocampus. CA3 afferent were stimulated to evoke population
spikes in the CA1 region. For data analysis, the criteria for animal inclusion included
recordings that exhibited stable evoked population spikes monitored for at least 30
minutes. The evoked field potentials were typically comprised of an initial positive-going
wave (PW) that was interrupted by a negative-going population spike (PS) followed by a
second PW (Fig. 2). The first PW primarily reflects synaptic depolarization whereas the
second PW corresponds to inhibitory influences occurring in CA1 cells. The population
spike is due to the summation of CA1 neurons discharging, and we quantified it as ‘the
vertical rise from peak negativity to the intersection point with a line drawn at a tangent
between the two PWs’. Samples of evoked potentials (n=3) are shown in Figure 17. In all
treatment groups pre-tetanus responses were successfully induced. With LTP taken to be
at 40% increase in post tetanus potentials over baseline responses. It can be deduced that
LTP was successfully induced in all groups at 60 minutes. The maintenance (180
minutes) of the response was however not pronounced in the METH treated animals. The
population spike amplitudes were not similar among the different animal groups and
exhibited amplitudes ranging between 3-8 mV for 7-day METH treated animals, 3-12
mV for the Post Washout animals, and 9-24 mV for Saline animals.. Taken together the
high frequency tetanic stimulation (100 Hz, 1 sec, three trains at 60 sec intervals)
produced both early-LTP and late-LTP in the Saline, Post Washout and METH groups.
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LTP across the CA3/CA1 region was defined as 40% greater than pre-tetanus levels
(100%). Results indicated that LTP was induced in all animal groups (n=3) but was more
robust in the Saline treated animals (Figures 18-21). LTP was classified as (1) early-LTP
(1-2 hours) and (2) late-LTP lasting beyond 2 hours. Presented in Figures 18-20 are
individual time plots of population spikes for Saline (n=1), 7 day METH (n=1) and Post
Washout (n=1). Figure 21 depicts the combine time plot of all treatment groups (n=3).
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Population Spikes

PW1
PW2

PS

Figure 17. Evoked population spikes showing LTP in the different guinea pigs (n=3)
hippocampus in vivo. The basic recording comprised of an initial positive-going wave
(PW) followed by second PW. Population spike amplitude was measured as the vertical
rise from peak negativity to the intersection point with a line drawn at a tangent between
the two PWs.
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Figure 18. Saline time plot of LTP across CA3/CA1 synapses in guinea pig hippocampus
in vivo. The graph is a plot of individual population spikes over the duration of the
experiment. Usually the pre tetanus response (last ten) is averaged together to get a pretetanus baseline response. Briefly, LTP was observed as significant population spike
enhancements of at least 40 % above pre-tetanus baseline responses. Early-LTP and lateLTP was developed and maintained in the saline group (n=1).
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Figure 19. Time plot of the 7 day METH. LTP across CA3/CA1 synapses in guinea pig
hippocampus in vivo. The graph is a plot of individual population spikes over the
duration of the experiment. Usually the pre tetanus response (last ten) is averaged
together to get a pre-tetanus baseline response. Briefly, LTP was observed as significant
population spike enhancements of at least 40 % above pre-tetanus baseline responses.
Early-LTP and late-LTP was developed and maintained in the METH group (n=1).
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Figure 20. Time plot Post Washout of LTP across CA3/CA1 synapses in guinea pig
hippocampus in vivo. The graph is a plot of individual population spikes over the
duration of the experiment. Usually the pre tetanus response (last ten) is averaged
together to get a pre-tetanus baseline response. Briefly, LTP was observed as significant
population spike enhancements of at least 40 % above pre-tetanus baseline responses.
Early-LTP and late-LTP was developed and maintained in the Post METH group (n=1).
L-LTP was more robust in Post Washout treatment group than the 7 day METH group.
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Figure 21. A combined time plot of LTP across the CA3/CA1 synapses in the guinea pig
(n=3) hippocampus in vivo. Briefly, LTP was observed as significant population spike
enhancements of at least 40 % above pre-tetanus baseline responses. Early-LTP and lateLTP were developed and maintained in all animal groups (n=3). However, L-LTP was
more robust on the Saline-only control group.
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3.2.2 Western blot

For the quantitative assay, equal amounts of protein from the 3 treatment groups
were electrophoresed concurrently. Samples were from taken from the 7 day METH
(n=6), Post Washout (n=6), and Saline (n=2) groups. The samples were transferred onto
the PVDF membranes, blotted with α-syn, developed and exposed to film as described in
the Method section. In Figure 22 we found that hippocampal protein samples probed with
polyclonal rabbit α-syn primary antibody (Santa Cruz Biotechnology; Santa Cruz, CA)
yielded specific bands that matched the expected size of guinea pig α-syn at 17kda. We
determined the densitometric measurements from the Western blots by using the Alpha
Ease FC 4.0 software, normalized against GAPDH and charted the results using the
Alpha Ease FC 4.0 software. Figure 22 showed the α-syn band expression of a single gel.
Figure 23 shows the histogram of the average densitometric measurement of individual
α-syn bands. The results (Figures 22 and 23) indicate higher levels of α-syn present in
the hippocampus of Saline-treated animals (n=2), and slightly decreased levels in the Post
Washout (n=6) and the METH groups (n=6). Taken together, our data raised the prospect
that there was a down regulation of endogenous α-syn protein levels in the hippocampus
between subgroup classifications; however, these differences were not statistically
significant.
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Alpha Synuclein Western Blot Film

Figure 22. Quantification of endogenous α-syn protein levels relative to the loading
control (GAPDH). Each band within a subgroup represents an individual guinea pig.
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Alpha Synuclein Densitometry

Figure 23. Western blot depicts α-syn expression normalized to the control GAPDH.
taken from the 7 day METH (n=6), Post Washout (i.e. 7 Day METH with WO; n=6), and
Saline (n=2) groups . The Saline group (n=2) shows a higher densitometry.
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4. Discussion

In the present study we investigated the memory performance of guinea pigs
(n=29) under varying METH treatments. The METH group was continually exposed to
METH (10mg/kg) per day for 7 days (n=10), Post Washout (n=12) was continually
exposed to METH (10 mg/kg) per day for 7 days followed by 7 “washout” days, and the
Saline group (n=7) was administered saline for 14 days and served as the control for this
experiment. We assessed the behavioral component through a NOR test and the plasticity
component through an Electrophysiology test to determine if memory consolidation
occurred in the animals. Additionally, we determined the levels of α-syn, a biochemical
marker that is implicated in neurodegenerative diseases such as Alzheimer’s and
Dementia Lewy bodies in the hippocampus, a brain region known to be involved in the
memory function. The key trends are that continual exposure to high dose METH results
in a loss of object recognition.
During the NOR behavioral assessment test, the guinea pigs (n=29) were given 5minute exposures to objects during the habituation, familiarization and the NOR phase
and a discrimination index (DI) was assessed. We determined time spent exploring each
object for the first 3 minutes during the different phases (i.e. Familiarization and NOR)
as applicable to calculate the DI. Finally we calculated the DI particularly between novel
object (NOV) and familiar object (FAM) as follows: DI = (Time exploring NOV – Time
exploring FAM)/ (Total time exploring NOV + FAM). Positive DI values indicated a
preference for the novel object which is suggestive of memory consolidation. After the
NOR test was assessed, the Saline group (n=7; DI= 0.63+/- 0.05) had the strongest
preference for the novel object followed by the Post Washout group (n=12; DI= 0.15 +/59

0.06) and finally the METH group (n=10; DI= -0.21 +/- 0.07). As a consequence, we
were able to obtain a reliable and robust measure of performance for the Saline group
(n=7). For future studies, an increase in the delay time from 3 hours to 24 hours or
longer can be used to see if memory consolidation was maintained between guinea pig
subgroups. It is worth noting that in studies by Luparini et al., (2000) when the period
between the presentation of objects was increased (24 h) these groups lost the ability to
recognize different objects. Increasing the time between the presentation of the familiar
and the new object rendered animals unable to recognize novelty beyond 3 hours.
In determining the effect METH has on synaptic plasticity, a key finding was in
the maintenance of late-LTP in animals treated with chronic METH (n=2). L-LTP was
achieved and was not maintained can be attributed to (1) too few animals were used
(n=2) and (2) the continuous infusion of METH in the brain may lead to a saturation
effect. However, when there are not enough animals used for the study only trends can be
suggested. One possible trend from the data is that METH treated animals may not
maintain late-LTP. Additionally, due to the continuous infusion of METH, a saturation
effect may have affected the process that lead to late-LTP. One possibility is that METH
has desensitized the dopamine receptors. It is interesting to note that rats that have been
treated chronically with METH for ninety days could not produce LTP (Chirwa et al.,
2005). It is suggestive from this data that the early and late phase of LTP was induced
and but only the late phase was not sustained. The second key finding is the POST
Washout group (n=2) that went through 7 days of continuous METH treatment followed
by 7 days of “washout” which also showed the l-LTP was not maintained. The early
phase of LTP was also induced in the hippocampus, but the late-LTP was not sustained
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What is interesting in this group is that they showed a positive DI for the novel object
during the NOR test which could suggest that after a “washout” period of METH
memory recognition can be achieved. However, the guinea pig did show some signs of
late-LTP but could not sustain it. A very likely possibility is small sample size of the
group (n=2) did not allow for sufficient data to be collected. A large group will give more
information that will lead to a more definitive conclusion.
In terms of molecular analysis of the guinea pig hippocampus expression, the
focus was α-syn for several reasons including the implication of this protein in
neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease whose major
symptom is memory loss. According to Kokhan et al., at the molecular and cellular level
α-syn deficient models may result in impairment of memory formation with aging
animals (2011). Another study reported that abnormal accumulation of α-syn in the
limbic system, particularly in the hippocampus, correlated with memory impairment and
led to structural synaptic deficits (Lim et al., 2011). Furthermore, when α-syn expression
was suppressed, partial clearing of pre-existing α-syn pathology and reversal of structural
synaptic defects was observed, resulting in an improvement in memory function (Lim et
al., 2011). Interestingly when α-syn expression was investigated in the hippocampus of
the guinea pigs for METH (n=6), Post Washout (n=6) and Saline (n=2) there was no
statistical significance in the results once it was normalized with the loading control
GAPDH. For instance, the present study did not measure the level of α-syn expressed in
the guinea pigs before the experimental procedures.

Additionally, the lack of

signifigance seen in α-syn could be due to reduce sensitivity of the protocol. Also more
sensitive tools areneeded such as probes with oligomers that are more specific and
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sensitive to α-syn in order to make a definite conclusion or comparison. Another reason
for the nature of protein expression could be the fact that METH can possibly alter α-syn
through post-translational modification on different parts of the protein because α-syn can
be over or under expressed A recent study by Lim et al., (2011) demonstrates the
suppression of α-syn expression can lead to the memory improvement. It is also a
possibility that METH does not have an effect on α-syn expression since the function of
α-syn is not widely known. We should have assessed protein or gene expression of α-syn
through different points in the experiment to establish a pattern of change instead of the
one point that we focused on. Α-syn that is usually seen in neurodegenerative diseases in
over expression or mutation could be trigged by other properties or mechanism in the
brain that causes the abnormality seen in neurodegenerative disease. With regards to this
project, the sample size was too small in order to effectively evaluate a mechanistic route
for METH, α-syn, and memory loss connections. This is only a stepping stone for the
effects of chronic METH on biochemical markers such as α-syn.
In summary, the present findings suggests chronic METH administration has an
affect on some of the same mechanisms underlining memory function and the druginduced activation lead to some form of memory impairments and the role of alpha
synuclein in the process of memory consolidation still remains unclear.
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